In 1978, DuPont demonstrated a series of oxazolidinones having in vitro antibacterial activity against human pathogens. The result of continuous investigations on this series resulted in DUP 105 & DUP 721 (Fig. 1 ) potent in vitro and in vivo antibacterial agents. [6] [7] [8] [9] In 1987, DUP 721 was selected as an antibacterial new candidate for clinical trials. However, its further development was discontinued due to toxicity observed in phase-I clinical trials. 10) The special features of their antibacterial activity attracted much attention and prompted studies on oxazolidinones in a number of laboratories. These are a novel class of synthetic antibacterial agents with activity against anaerobic and gram-positive bacteria. 11) They represent the first new antimicrobial class to be released onto to market over a decade and are structurally unrelated to any other compounds currently in the market.
The Pharmacia-Upjohn scientists were able to identify two drug candidates for human studies linezolid and eperezolid 10) (Fig. 1 ). The linezolid which was discovered is well known as the first promising candidate of oxazolidinones and works effectively against numerous serious gram-positive pathogens like methicillin resistant Staphylococcus aureus (MRSA), Staphylococcus epidermidis, vancomycin resistant enterococci (VRE) and penicillin resistant pneumococci. 1, 11) Oxazolidinones are an appealing class of antimicrobials due to their unique bacteriostatic mechanism of action. [They have been shown selectively and uniquely to bind 50s ribosomal subunit and inhibit translation], lack of cross resistance with other antibacterial agents, good oral bioavailability, potential for structural manipulation. 1, 5, 12) New agents with greater potency and new spectra of activity could arise from the further modification of oxazolidinone nucleus. The potential of this oxazolidinones stimulated an exploratory chemical program in our Drug Discovery Laboratories.
Chemistry The synthesis of oxazolidinone basic moiety (compound A) was accomplished by the procedures, which have been described previously 8, 10) (Chart 1). The thioanisole (0.264 g, 2.12 mmol) was added to a solution of compound A (0.250 g, 0.51 mmol) in dichloromethane (15 ml) under stirring at 0°C and continued the stirring for 6 h. To the resulted reaction mass trifluoroacetic acid (0.96 g, 8.4 mmol) in DCM (10 ml) was added drop wise under stirring at the same condition. The completion of the reaction was confirmed by TLC, using ethyl acetate-hexane as solvent system. Then the reaction mass was neutralized with triethylamine (2.17 g, 21.4 mmol) at 0°C to yield the compound B.
Example: The triethylamine (0.283 g, 2.77 mmol) followed by 4-chlorophenyl isothiocyanate (0.107 g, 0.63 mmol) was added to the solution of compound B (obtained above) in DCM (15 ml) at 0-4°C under stirring. Continued the stirring at the same temperature for 15 min and further stirring continued at 30°C for 2 h. After completion of the reaction, the resulted reaction mass was sonicated for 15 min after addition of water (20 ml) and hexane (20 ml) to yield white color final compound (compound 1, 244 mg, 86%) (Chart 2).
Further following the procedure mentioned above the compounds 2-13 were synthesized using compound B (Table 1) . Structure Activity Relationship The antibacterial oxazolidinone pharmacophore (Fig. 2) consists of an oxazolidinone ring, ('A' ring), 'B' ring (aromatic ring) attached at nitrogen of the 'A' ring, 'C' ring (piperazinyl ring) is present as the substituent on 'B' ring. Oxazolidinone pharmacophore also tolerates another substituted aromatic ring ('D' ring) attached to a piperazinyl ring ('C' ring) as a substituent. The substitution at 3rd and 5th position and stereochemistry of the substitution at 5th position of the oxazolidinone ring plays a critical role in the antimicrobial activity. The 5-(S)-configuration is necessary for activity. The substituent amidomethyl group at C-5 imparts improved activity. And 3-N-aryl group (Ring 'B') is essential for activity. 12) In view of this, Ring A, Ring B and Ring C moieties were kept unchanged.
Synthesis and Evaluation of Urea and Thiourea Derivatives of Oxazolidinones as Antibacterial Agents
The synthesized molecules (Table 1) were tested for in vitro antibacterial activity against clinical isolates and quality control organisms using linezolid as reference compound. The minimum inhibitory concentrations (MICs) of these compounds were listed in Table 2 . For convenience these compounds were discussed as urea derivatives and thiourea derivatives. Interestingly it is found that the ortho and meta substituted phenyl urea derivatives (11, 12) showed comparable activity against gram-positive organisms and moderate activity against gram-negative organisms to that of linezolid. As increasing the substitution at phenyl ring the potency seems to be decreased (5, 13). It was clear from the study that the mono halo substitution on ring D showed comparatively potent activity than the others. (9) and p-dichloro (10) substitution of D ring showed moderate activity against gram-positive organisms and exhibited poor activity against gram-negative organisms.
Thirteen urea and thiourea derivatives were synthesized No.
Reagents: i) CH 3 CN, 70°C; ii) BOC anhydride, THF, 0-25°C; iii) 10% Pd/C, EtOAc, 40 psi; iv) Cbz, DMA, THF, 0-25°C; v) n-butyl lithium, R-(Ϫ)-glycidyl butyrate, THF, Ϫ78°C; vi) CH 3 SO 2 Cl, NEt 3 , DCM, 0-25°C; vii) NaN 3 , DMF, 60-70°C; viii) 10% Pd/C, EtOAc, pyridine, acetic anhydride.
Chart 1
Reagents: i) TFA, thioanisole, DCM, NEt 3 ; ii) NEt 3 , 4-chlorophenyl isothiocyanate, DCM.
Chart 2
Fig . 2 and the MIC was determined for all the derivatives except for compound 5. From the MIC values depicted in Table 2 it can be concluded that urea derivatives (compounds 4, 11, 12, 13) are more potent than thio urea derivatives (compounds 1, 2, 3, 6, 7, 8, 9, 10).
3D QSAR To gain further insight into the structure-activity relationship of these oxazolidinone antibacterial and to derive a predictive three-dimensional quantitative structure activity relationship (3D-QSAR) model, we made use of the Genetic Function Approximation algorithm (GFA) in cerius 3.
GFA algorithm offers a new approach to building structure activity models. It automates the search for QSAR models by combining a genetic algorithm with statistical modeling tools (Thousands of candidate models are created and tested during evolution only the superior model survives.). GFA has been successfully applied for generation of 3D-QSAR models which can be used for designing newer compounds and activity prediction prior to synthesis. 3) GFA predicted values are given in Table 3 .
Study Set: MIC data against various strains analyzed for the standard linezolid and 11 molecules synthesized were presented (Table 2) . MIC values for S. aureus MRO 00001 presents a range of value than others. 3D structures of molecules were constructed on a 3D computer graphics interface. Structures were improved by minimizing the conformational energy by molecular mechanics and semi empirical quantum mechanics. All the molecules were superimposed and they are aligned in a grid box. Interactive energies were calculated using CH 3 as steric parameter and H ϩ as electrostatic parameter their values are entered as descriptors.
Thousands of descriptors are generated among them only with 10% variance were used in generating the QSAR equation.
GFA-correlates activity with descriptors and checks the stability of the QSAR model. Final sets of GFA models were analyzed statistically to select the best model. n is the number of compounds used in the study, r represents the correlation coefficient which is the measure of quality of fit of the model. r2 is the square of correlation coefficients. Xvr2 is cross-validated r2. PRESS predicted residual errors of sum of squares, which is the sum of squared deviations 
Conclusion
From the MIC data it can be concluded that the compounds 11 and 12 are having close activity to the comparator linezolid, whereas rest of the compounds are possessing moderate activity. The 3D-QSAR studies reveal that electropositive substitution at field point Hϩ/138 near the orthoposition of the terminal phenyl ring will increase the activity. Hence promising antibacterial agents can be synthesized by placing electron with drawing groups at the ortho-position of the phenyl ring.
Experimental
Melting points were determined on Buchi B-540 automatic melting point apparatus and are uncorrected. Infrared spectra were recorded in KBr on Perkin-Elmer Paragon-1000 model. 1 H-NMR spectra were obtained in solvent DMSO-d 6 using Brukes-400 spectrometer, TMS as internal standard.
(S)-N-[3-{N-(4-Chlorophenyl)-4-(3-fluorophenyl)piperazine]-1-carbothioamido}-2-oxooxazolidin-5-yl)methyl]acetamide (1)
The triethylamine (0.283 g, 2.77 mmol) followed by 4-chlorophenyl isothiocyanate (0.107 g, 0.63 mmol) were added to the solution of compound B (obtained according to the procedure described in the chemistry section) in DCM (15 ml) at 0-4°C under stirring. Continued the stirring for 15 min at the same condition and further stirring continued at 30°C for 2 h. After completion of the reaction, the resulted reaction mass was sonicated for 15 min after addition of water (20 ml) and hexane (20 ml) to yield white color final compound, (compound 1, 244 mg, 86%), (mp 210-214°C) IR (cm The triethylamine (0.283 g, 2.77 mmol) followed by 2-chlorophenyl isothiocyanate (0.097 g, 0.57 mmol) were added to the solution of compound B and further following the procedure described for compound 1 afforded the title compound (compound 9) (225 mg, 78%) an off white solid, (mp 138-140°C). IR (cm 
